Prevalence, Grades and Management of Prostate Cancer among Men Attending Oncology Unit at Bugando Medical Centre Mwanza, Tanzania
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Epidemiology
- Vol. 12 (02), 146-157
- https://doi.org/10.4236/ojepi.2022.122013
Abstract
Background: Prostate cancer is the second most frequent cancer in men after lung cancer, it accounts for 3.8% of all deaths caused by cancer in men worldwide. This study aimed at determining the prevalence, grades and management of prostate cancer among male patients admitted with cancer at Oncology Department of Bugando Medical Centre. Methodology: This was a hospital-based retrospective cross-section study that retrieved data from 384 medical files of male patients admitted with cancer in Oncology wards at Bugando Medical Centre from January 2017 to December 2020. Results: The prevalence of prostate cancer was 39.84% (153 of 384 male patients). The mean age of patients with prostate cancer was 64.85 years ± 14.59 years. Two third of the patients’ prostate cancer were graded at presentation and of these, 52.58% (51 of 97) were having a high grade prostate cancer of Gleason scores 8, 9 or 10. Treatment involved hormonal therapy, chemotherapy and Radiotherapy whereby 49.48% (n = 190) were treated with hormonal therapy (Goserelin and Bicalutamide), 32.03% (n = 123) with combination of hormonal and chemotherapy, (Goserelin, bicalutamide and docetaxel or paclitaxel), 15.69% (n = 60) with combination of radiotherapy and hormonal therapy and 2.6% (n = 11) with chemotherapy alone (Docetaxel). Conclusion: The study found high prevalence of prostate cancer among male patients, majority with high grade form and limited options of treatment. Frequent screening and awareness programs should be conducted to enable early detection to reduce its morbidity and mortality. Patient on treatment should be followed up to determine their response to treatments.Keywords
This publication has 23 references indexed in Scilit:
- International Variation in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2012
- Prostate Cancer Incidence Rates in AfricaProstate Cancer, 2011
- Case series of adenocarcinoma of the prostate associated with Schistosoma haematobium infection in TanzaniaJournal of Global Infectious Diseases, 2010
- Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature ReviewEuropean Urology, 2009
- Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA eraProstate Cancer and Prostatic Diseases, 2008
- The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort StudyEuropean Urology, 2008
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, 2007
- A Review and Meta-Analysis of Prostate Cancer UtilitiesMedical Decision Making, 2007
- Risk factors for prostate cancer incidence and progression in the health professionals follow‐up studyInternational Journal of Cancer, 2007
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterThe New England Journal of Medicine, 2004